MAAT INDEX

CLAIM #56591 · Thermo Fisher Scientific Inc (TMO) · 2025Q4 earnings call · Jan 29, 2026 · due Dec 31, 2026

And as we progress through 2026, we can retire risk as we go and progress higher in the range.

Stephen Williamson · CFO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Full-year 2026 organic revenue growth rate, as reported

It came true if: Full-year 2026 organic revenue growth exceeds the guided midpoint of slightly above 3% (i.e., >3.0%)

Where: Company quarterly/annual earnings releases and management commentary (10-K / Q4 2026 earnings call)

In context

million revenue tailwind from foreign exchange, and 50 basis points of adjusted operating margin expansion. All of this will enable a really strong 6% to 8% growth in adjusted EPS. This guidance is consistent with the financial framing for '26 and '27 that we shared with you back on our Q2 earnings call. It reflects the continued improvement in our organic growth in 2026 coupled with very strong earnings growth. The strength of our guidance reflects our industry-leading position, our proven growth strategy, and the power of our PPI business system. Let me now provide some detailed context behind the guide. The midpoint of our guidance assumes organic revenue growth is slightly above 3%. This is a step up from 2025. We think this is appropriate to start at 3% at the beginning of the year. And as we progress through 2026, we can retire risk as we go and progress higher in the range. As is our normal practice, we've not included any future acquisitions or divestitures within our guidance. The guide, therefore, does not include the benefit of the pending acquisition of Clario. As a reminder, we expect this deal to close by 2026. Should that be the case, we would expect $0.20 to $0.25 of incremental adjusted EPS for this year, reflecting the strongly accretive nature of the acquisition. That would represent roughly one additional point of adjusted EPS growth for 2026, taking the total company growth into the range of 7% to 9%. In terms of the macro environment, our guidance is based on the tariffs that are in place as of today. It doesn't contemplate any future changes in tariffs nor their potential impact on FX rates. Should additional tariffs be levied, as we did last

Verify independently

SEC filings for TMO · Claim quote is verbatim from the 2025Q4 earnings call.